The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis | Zendy

AI Assistant Blog Pricing

The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.